BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013

Apr 23, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-04-19

Reporting Person: Ajer Jeffrey Robert (SVP, Chief Commercial Of)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-04-19	Common Stock	M	5000	$21.51	Acquired	15570	Direct
2013-04-19	Common Stock	S	5000	$65.00	Disposed	10570	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-04-19	Stock Option (right to buy) Common Stock	$21.51	M	5000	Disposed	2020-05-11	Common Stock (5000)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 plan executed on December 11, 2012.

F2: Original option grant vests 6/48th on November 12, 2010 and 1/48th on the 12th of each month thereafter.

F3: Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.